Galderma Group Ltd header image

Galderma Group Ltd

GALD

Equity

ISIN CH1335392721 / Valor 133539272

SIX Swiss Exchange (2026-08-06)

CHF 178.25-0.11%

Galderma Group Ltd
UMushroom community rating:

4.33 3 votes No rating yet

NegativeNeutralPositive

About company

Galderma Group Ltd is a leading company in the dermatology sector, focusing exclusively on this field for over 40 years. The company specializes in developing, manufacturing, and marketing a wide range of dermatological treatments and solutions. Galderma's product portfolio includes therapeutic dermatology products, dermatological skincare, and injectable aesthetic treatments, catering to a diverse range of skin health needs. With a global presence, the company operates research and development centers and manufacturing facilities strategically located around the world. Galderma is dedicated to advancing the field of dermatology through continuous innovation and science-based solutions, aiming to enhance the quality of life for patients with various skin conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

40.0%1Y

%3Y

%5Y

Performance

28.1%1Y

30.8%3Y

30.8%5Y

Volatility

51431 M

Market cap (USD)

288,820

Daily traded volume (Shares)

100.6 / 98.35

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.33

3 votes

Performance:

4.00

Innovation:

4.00

Society:

3.00

Nature:

2.67

Laura Bischofberger

Switzerland, 12 Jun 2024

New kid on the block, lets see where they go after they IPO.

Hein Sweerts de Landas

Switzerland, 12 Jun 2024

It's the trend, personal beautification. Online: photoshop, real world: Galderma!

Admin UMushroom

Switzerland, 12 Jun 2024

Was never too keen on this type of procedures.

EQUITIES OF THE SAME SECTOR

BridgeBio Pharma Inc

BridgeBio Pharma Inc Valor: 48204826

Annual Return

-50%0%+50%

Risk level

110

0.99%USD 82.80

Alkem Laboratories Ltd.

Alkem Laboratories Ltd. Valor: 30689895

Annual Return

-50%0%+50%

Risk level

110

-0.96%INR 5,608.45

Insmed Inc

Insmed Inc Valor: 12614415

Annual Return

-50%0%+50%

Risk level

110

33.86%USD 132.55

Laurus Labs Ltd.

Laurus Labs Ltd. Valor: 56464789

Annual Return

-50%0%+50%

Risk level

110

-0.36%INR 1,836.00

Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited Valor: 11500585

Annual Return

-50%0%+50%

Risk level

110

2.27%INR 834.60

Narayana Hrudayalaya Ltd.

Narayana Hrudayalaya Ltd. Valor: 30795490

Annual Return

-50%0%+50%

Risk level

110

-0.98%INR 1,883.80

Metropolis Healthcare Ltd.

Metropolis Healthcare Ltd. Valor: 11536062

Annual Return

-50%0%+50%

Risk level

110

-2.76%INR 562.55

Cohance Lifesciences Ltd

Cohance Lifesciences Ltd Valor: 46346459

Annual Return

-50%0%+50%

Risk level

110

2.54%INR 439.85

Gland Pharma Ltd.

Gland Pharma Ltd. Valor: 56038514

Annual Return

-50%0%+50%

Risk level

110

2.82%INR 2,617.50

MEDICLIN AG

MEDICLIN AG Valor: 1158721

Annual Return

-50%0%+50%

Risk level

110

-2.31%EUR 4.22

SIX

FactSet

Clearbit

Logos provided by Clearbit